Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma
Endocrine-Related Cancer · 2025
DOI: 10.1530/erc-24-0344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2025. Verfasst von Luna Picello und 13 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
The genetic component is thought to play an important role in the development of familial non-medullary thyroid carcinoma (fNMTC), but the involved molecular mechanisms and genes are poorly understood. The MAPK kinase cascade, particularly involving RAS and BRAF, is crucial in cancer development, with RIN1 emerging as a notable gene due to its differential expression across various tumor types. We identified a frameshift mutation (c.798delC: p.V267Sfs*83) in the RIN1 gene in a family with non-medullary thyroid cancer (NMTC) through whole-exome sequencing. Paraffin-embedded tumor tissues were analyzed to investigate the mutation’s characteristics and its potential implications within the thyroid cellular context. Functional assays and RNA sequencing using CRISPR/Cas9-edited Nthy-ori 3-1 thyroid cell line and xenograft zebrafish models confirmed the mutation effect and the putative RIN1 tumor suppressor role. The study revealed significant alterations in cellular behavior upon RIN1 knockout, including increased cell viability, proliferation and colony formation, alongside morphological changes indicative of epithelial–mesenchymal transition. Enhanced phosphorylation of ERK and AKT suggested MAPK pathway dysregulation following RIN1 depletion, supporting its potential tumor suppressive role. Phenotypic rescue experiments confirmed that reintroduction of wild-type RIN1 restored normal cellular behavior. RNA sequencing demonstrated differential gene expression between RIN1 −/− and control cells, particularly affecting pathways associated with cancer progression, closely resembled signatures specific to NMTC. This study provides compelling evidence supporting RIN1 as a tumor suppressor gene within thyroid cells. In addition, the findings highlight its potential significance as novel gene involved in FNMTC pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Laura Fugazzola, Giovanni Vitale, Gianluca Occhi
Zitieren
APA
Picello, L., Dalle Nogare, M., Puggina, D., Salvoro, C., Pennelli, G., Gaudenzi, G., Carra, S., Oldani, M., Gentilini, D., Fugazzola, L., Faggiano, A., Vitale, G., Occhi, G., & Vazza, G. (2025). Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0344
Vancouver
Picello L, Dalle Nogare M, Puggina D, Salvoro C, Pennelli G, Gaudenzi G, et al. Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma. Endocrine-Related Cancer. 2025. doi:10.1530/erc-24-0344
BibTeX
@article{Picello2025,
author = {Picello, Luna and Dalle Nogare, Mattia and Puggina, Daniele and Salvoro, Cecilia and Pennelli, Gianmaria and Gaudenzi, Germano and Carra, Silvia and Oldani, Monica and Gentilini, Davide and Fugazzola, Laura and Faggiano, Antongiulio and Vitale, Giovanni and Occhi, Gianluca and Vazza, Giovanni},
title = {Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma},
journal = {Endocrine-Related Cancer},
year = {2025},
doi = {10.1530/erc-24-0344}
}
EUVIMED